Delivery Order SPE2DB22D9353-SPE2DB25FX1VN
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,536.74 by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of VisionBlue 0.06% syringes in 0.5ml quantities. The contract operates under a firm fixed-price structure with an ultimate completion date of May 15, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,382.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 19, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, covers the supply of VisionBlue 0.06% syringes in 0.5ml units. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits within the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,073.48 contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML. The order has a period of performance through June 30, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- The Defense Logistics Agency awarded a delivery order valued at $1,691.16 to DMS Pharmaceutical Group Inc. on July 17, 2025, for the supply of VisionBlue 0.06% syringes in 0.5mL quantities. This firm fixed-price delivery order, with an ultimate completion date of August 7, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The award carries no set-aside designation, allowing DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,382.32 by the Defense Logistics Agency on September 26, 2025, for VisionBlue 0.06% syringes in 0.5ML quantities. This firm fixed-price delivery order, with an ultimate completion date of October 20, 2025, represents a continuation of the company's substantial pharmaceutical supply relationship with the Defense Logistics Agency. The award...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for VisionBlue 0.06% syringes in 0.5mL quantities. This firm fixed-price delivery order, valued at $8,455.80, is scheduled for completion by September 23, 2025, and was awarded on September 2, 2025. The award carries no set-aside designation, allowing the vendor to compete on a competitive basis. DMS Pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,382.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 28, 2025. This firm fixed-price delivery order is for VisionBlue 0.06% Syringe 0.5ML, an ophthalmic pharmaceutical product, with a completion date of September 19, 2025. The award was made without a set-aside designation, and performance will occur at the contractor's facility in Park...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,634.04 firm fixed-price delivery order is for the supply of VisionBlue 0.06% syringes with a 0.5ML capacity. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) with DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,691.16 on June 18, 2025, for VisionBlue 0.06% syringes in 0.5 mL quantities. The contract, which carries no set-aside designation, is a firm fixed-price delivery order with an ultimate completion date of July 11, 2025. The place of performance is located in Park Ridge, Illinois, and the funding agency is the Defense Logistics Agency (DLA),...
- This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,634.04, was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of June 18, 2024. The contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML, which is a pharmaceutical product. DMS Pharmaceutical Group Inc. has an Indefinite Delivery Contract (IDC) with...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX1VNDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $3,382.32 to DMS Pharmaceutical Group Inc. on April 24, 2025, for the supply of VisionBlue 0.06% syringes in 0.5mL quantities. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform delivery at its Park Ridge facility with an ultimate completion date of May 15, 2025. This delivery order was issued without a set-aside designation, allowing the contractor to compete on an unrestricted basis. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering prescription medications, biologics, medical consumables, and specialty pharmaceutical products to Department of Defense healthcare sites. The company's portfolio encompasses treatments ranging from contraceptive devices to oncology medications and injectable products, positioning it as a key distributor of both branded and generic pharmaceuticals to federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 4/24/25 |